Johnson & Johnson hits the Big Apple with latest JLabs site

Johnson & Johnson (NYSE:JNJ) opened its latest life science incubator in New York City, the healthcare giant said today. The 30,000-square-foot JLabs @ NYC is a collaboration between Johnson & Johnson Innovation, New York State and the New York Genome Center. Sited at the genome center in SoHo, the incubator is home to 26 startups and

Johnson & Johnson launches new self-shortening Dynacord suture

Johnson & Johnson through its DePuy Synthes franchise has announced the U.S. launch of its Dynacord suture for soft tissue repair in areas such as the rotator cuff in the shoulder. The Dynacord suture, available on Healix Advance anchors, is part of the DePuy Synthes Mitek Sports Medicine portfolio. J&J launched Dynacord today at the San

Stryker, Boston Scientific tie-up could create ‘higher growth Medtronic’

Analysts are eagerly digging into the news that Stryker (NYSE:SYK) put in a takeover bid with Boston Scientific (NYSE:BSX), though many were surprised by the news and are unsure of the obvious strategic value of the acquisition. News of the deal, which both companies have officially responded to with statemens of “no comment,” emerged yesterday at the […]

Fortive offers $2.8B for J&J’s advanced sterilization biz

Johnson & Johnson (NYSE:JNJ) said yesterday that industrial conglomerate Fortive (NTSE:FTV) made a binding offer to acquire the advanced sterilization business from J&J’s Ethicon division for approximately $2.8 billion. The deal includes $2.7 billion in cash and an additional $100 million in retained net receivables, New Brunswick, N.J.-based Johnson & Johnson said. J&J’s advanced sterilization products biz […]

Power morcellation: Questions linger for controversial tech

Dr. Amy Reed’s tragic case brought to light the cancer risks posed by power morcellation. Her death hasn’t stopped lingering questions about the technology. Power morcellators were used for 20 years to laparoscopically remove fibroids, benign tumors of the uterus, raising not a single adverse event report with the FDA. That all changed in 2013,

Stryker, J&J and Abbott ranked as top companies to work at in the U.S.

Stryker, Johnson & Johnson and Abbott have been named as some of LinkedIn’s top companies to work at in 2018. This marks the third year of “LinkedIn’s Top Companies 2018: Where the U.S. wants to work now,” which names the companies that professionals most want to work at based on a set of data points collected

Medtech stories we missed this week: April 6, 2018

From CHF Solutions’s distribution deal to Guided Therapeutics’s licensing agreement, here are seven medtech stories we missed this week but throught were still worth mentioning. 1. CHF inks Spanish distribution deal CHF Solutions announced in an April 5 press release that it has signed a distribution agreement with Dimedix Surgical. The distribution agreement will allow

J&J chief Gorsky bullish on tax reform, plans $16B in repatriated overseas cash

Johnson & Johnson (NYSE:JNJ) chief executive Alex Gorsky is bullish on the newly passed US tax reform, according to a new interview with CNBC. Gorsky said that with the passing of the new tax reform bill last month, New Brunswick, N.J.-based Johnson & Johnson plans to repatriate $16 billion in overseas cash, according to the interview. […]

The 10 largest medical device companies in the world

Mergers & acquisitions continue to change the medical device landscape, as reflected in Medical Design & Outsourcing’s new Big 100 list. We pulled financial regulatory filings and reached out to major companies in some cases to create a list of the 100 largest medical device companies in the world, ranked by annual revenue for their

Pages: 1 2 3 4 5 6 7 8 9 10 11

This 3D printed implant replaces skull bone

A New Jersey doctor turned to Johnson & Johnson’s DePuy Synthes and a 3D printed implant to replace missing skull bone in a patient. The procedure was performed after the patient suffered brain swelling and the skull became infected. Dr. Gaurav Gupta, assistant professor of neurosurgery at Rutgers Robert Wood Johnson Medical School, had to

Want to sell your medtech startup? Be one of these three things

Peter Stebbins meets with a lot of medtech startups as medical device transactions lead at Johnson & Johnson Innovation in Boston. Often, they could benefit from a better grasp of what a buyer is looking for. “It’s not infrequent that someone with an idea perceives it should make sense to J&J, but they don’t understand where our

Johnson & Johnson Innovation backs 3D printing, coatings and contact lenses

Johnson & Johnson Innovation, the incubation arm of healthcare giant Johnson & Johnson (NYSE:JNJ), said today that it’s investing in a variety of medical device and pharmaceutical programs, including 3D printing, coatings and contact lenses. The new”investments and strategic transactions” feature a joint effort with MIT spinout Inkbit Corp., which is developing “a unique multi-material

UVA developing smartphone-controlled artificial pancreas

University of Virginia (UVA)  researchers are working on changing the lives of diabetic patients with an artificial pancreas that can be controlled using a smartphone. An artificial pancreas is a system that mimics the function of a healthy pancreas and regulates glucose. The system that UVA researchers developed is a two-part system. A smartphone uses